الرئيسية
المتابعة المباشرة
5282
آخر الأخبار الحية الآن
الاكتشاف والفرز
98
المبكر: 78
الفرص
98
الذهبي: 2 | المبكر: 78
آخر الأخبار المتحرك
حالة السوق الآن
أبرز خبر الآن

Agenus Reports Phase II Data Demonstrating Immune Reprogramming and Durable Survival with Botensilimab, Balstilimab and agenT-797 in PD-1 Refractory Gastroesophageal Cancer First study combining botensilimab (BOT) and balstilimab (BAL) with agenT-797 in gastroesophageal cancer shows disease control rate (DCR) of 77% in patients and long-term survival beyond 20 months in a subset of

AGEN | benzinga_dom_ingest | 2026-04-18 18:57:16
AGEN benzinga_dom_ingest general
الأخبار5282
المبكر78
الذهبي2
الفرص98

آخر 10 أخبار بالترتيب الفعلي

2026-04-18 18:57:16
AGEN
Agenus Reports Phase II Data Demonstrating Immune Reprogramming and Durable Survival with Botensilimab, Balstilimab and agenT-797 in PD-1 Refractory Gastroesophageal Cancer First study combining botensilimab (BOT) and balstilimab (BAL) with agenT-797 in gastroesophageal cancer shows disease control rate (DCR) of 77% in patients and long-term survival beyond 20 months in a subset of
benzinga_dom_ingest | general
2026-04-18 18:57:16
RPAY
REPAY Confirms Receipt of Unsolicited, Non-Binding Proposal from Forager Capital Management No Stockholder Action is Required at this Time Repay Holdings Corporation (NASDAQ:RPAY) ("REPAY" or the "Company"), a leading provider of integrated payment processing solutions, today confirmed receipt of an
benzinga_dom_ingest | general
2026-04-18 18:57:16
AGEN
Agenus Announces Phase II Data Showing Immune Reprogramming and Durable Survival with Botensilimab, Balstilimab And agenT-797 in PD-1 Refractory Gastroesophageal Cancer; The Study Did Not Meet Its Primary Endpoint Of ORR First study combining botensilimab (BOT) and balstilimab (BAL) with agenT-797 in gastroesophageal cancer shows disease control rate (DCR) of 77% in patients and long-term survival beyond 20 months in a subset of heavily BZ Wire
benzinga_dom_ingest | general
2026-04-18 18:57:16
BOLD
Boundless Bio Presents Preclinical Breast Cancer Data from its Oral Kinesin Degrader Program at 2026 AACR Annual Meeting SAN DIEGO, April 17, 2026
benzinga_dom_ingest | fda
2026-04-18 18:57:16
RPAY
Repay Confirms Receipt Of An Unsolicited, Non‑binding Proposal From Forager Capital Management; Says It Will Review The Proposal In Consultation With The Company's Financial And Legal Advisors; Stockholders Are Not Required To Take Any Action At This Time BZ Wire
benzinga_dom_ingest | general
2026-04-18 18:57:16
BOLD
Boundless Bio Reveals Preclinical Breast Cancer Data from its Oral Kinesin Degrader Program at 2026 AACR Annual Meeting Boundless Bio (NASDAQ:BOLD), a clinical-stage oncology company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to patients with previously intractable oncogene amplified cancers, BZ Wire
benzinga_dom_ingest | fda
2026-04-18 18:57:16
SMTK
SmartKem Files Prospectus To Issue And Sell Up To 146.8M Common Shares To Keystone Capital Partners -SEC Filing BZ Wire
benzinga_dom_ingest | general
2026-04-18 18:57:16
IWM
+5 Russell 2000 Rips To Record High — Here Are The Top Small Cap Gainers The small-cap Russell 2000 punched through to an intraday record high on Friday, capping a furious 13-day rally. BZ Wire
benzinga_dom_ingest | general
2026-04-18 18:57:16
CJMB
Callan JMB Issues Statement on Recently Filed Lawsuit by Eddie Patent Holdings LLC Spring
benzinga_dom_ingest | mna
2026-04-18 18:57:16
SOWG
Sow Good Announces 15-To-1 Reverse Stock Split Effective On April 23, 2026 Irving, TX – April 17, 2026 — Sow Good Inc. (NASDAQ:SOWG), a freeze-dried food and candy manufacturer, announced today that its Board of Directors has approved a 15-to-1 reverse stock split (the "reverse stock split"), BZ Wire
benzinga_dom_ingest | general

المتابعة المباشرة

الأقسام التي يتم فيها ما يحدث الآن مباشرة في السوق والنظام.

الاكتشاف والفرز

الأدوات التي تخرج فرصًا أو قراءات مبكرة أو تصفيات سريعة.

النظام والمراقبة

الفحص السريع وحالة الصفحة الرئيسية وتحديثها.

نوع الصفحة
سناب شوت
يتم تحديد النمط تلقائيًا حسب المسار.
آخر تحميل: —